EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antifungal susceptibility and molecular characterization of clinical and environmental isolates of Schizophyllum commune

Grégoire Pasquier iD, Pierre-Olivier Harmand, Laura Le Feur, Emilie Guemas, Anne Pauline Bellanger, Danièle Maubon, Anne Favel, Claire Cottrel, Lilia Hasseine, Marcela Sabou, Eric Dannaoui iD, Arnaud Fekkar iD und 5 weitere

Journal of Clinical Microbiology · 11.03.2026 · 64 (3)

DOI: 10.1128/jcm.01442-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Microbiology, erschienen am 11.03.2026. Verfasst von Grégoire Pasquier und 16 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de Parasitologie-Mycologie, CHU de Montpellier, Montpellier, France. Hauptthemen laut MEDLINE: Schizophyllum, Mycoses, Respiratory Tract Infections, Antifungal Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schizophyllum commune is a cosmopolitan, saprophytic basidiomycete known to cause respiratory tract infections following spore inhalation. Management of such infections remained poorly defined, and antifungal susceptibility testing may provide valuable guidance for therapeutic decisions. However, existing data are limited, and protocols are not optimized for non-sporulating molds such as S. commune , requiring methodological adaptations. This study aimed to (i) perform molecular characterization of isolates and (ii) determine antifungal susceptibility profiles of a collection of S. commune isolates using both Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) reference methods. A total of 113 fungal isolates were included, comprising environmental ( n = 31), clinical French isolates ( n = 74), and strains from fungal international collections ( n = 8). Species identification was confirmed via the large subunit (LSU) region of the ribosomal DNA sequencing and by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Phylogenetic analysis was conducted on a subset of 20 isolates using partial sequences of three genes: LSU, EF-1α, and RPB2. Modifications to the CLSI and EUCAST broth microdilution methods included: inoculum preparation using standardized culture slices fragmented by bead-beating, incubation at 35°C for 96 h and endpoints reading at 100% of inhibition. Phylogenetic analysis confirmed that all tested isolates were S. commune and not S. radiatum . Amphotericin B (AMB) and voriconazole (VOR) demonstrated low geometrical mean minimal inhibitory concentrations (MICs) across both methods (EUCAST: AMB = 0.39 µg/mL, VOR = 0.24 µg/mL; CLSI: AMB = 0.1 µg/mL, VOR = 0.2 µg/mL). In contrast, terbinafine exhibited high MIC values (>8 µg/mL) in both protocols. Notable discrepancies were observed for posaconazole (POS), isavuconazole (ISA), and itraconazole (ITR), with MICs approximately two dilution steps higher in EUCAST compared to CLSI (POS: 4.22 µg/mL vs 0.9 µg/mL, ISA: 3.64 µg/mL vs 0.74 µg/mL, and ITR: 3.9 µg/mL vs 0.81 µg/mL, respectively). After standardization of both methods for this non-sporulating mold, VOR and AMB have the lowest MIC values. IMPORTANCE Schizophyllum commune is a fungal pathogen increasingly associated with respiratory infections, yet therapeutic guidance remains unclear. This study provides the largest collection to date of clinical and environmental isolates (113 total) and applies standardized antifungal susceptibility testing using adapted EUCAST and CLSI protocols for this non-sporulating species. The results show that amphotericin B and voriconazole are the most active agents in vitro , while terbinafine is ineffective. These findings are critical for informing treatment decisions and interpreting susceptibility tests, especially in the absence of established guidelines. By introducing a reproducible methodology and delivering clinically relevant data, this work addresses a gap in medical mycology and supports improved management of rare fungal infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophyllumMycosesRespiratory Tract InfectionsAntifungal AgentsMicrobial Sensitivity TestsDNA, FungalDNA, EnvironmentalSequence Analysis, DNAHumansPhylogenyAmphotericin BVoriconazoleTerbinafineGenes, Fungal

Stichwörter der Autor:innen

CLSIEUCASTSchizophyllum commune or radiatumantifungal susceptibilitystandardization

Substanzen

Antifungal AgentsDNA, FungalDNA, EnvironmentalAmphotericin BVoriconazoleTerbinafine

Autor:innen und Institutionen

  • Laboratoire de Parasitologie-Mycologie, CHU de Montpellier, Montpellier, France.
  • UMR MIVEGEC, Université de Montpellier, Montpellier, France.
  • Service de Parasitologie-Mycologie, Hôpital Purpan, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
  • Parasitology-Mycology Department, Besancon University Hospital, Besancon, France.
  • Translational Innovation in Medicine and Complexity, Centre National de la Recherche Scientifique, Université Grenoble Alpes, Domaine de la Merci, Centre Hospitalier Universitaire Grenoble Alpes, Service de Parasitologi…
  • INRAE, Aix Marseille Univ, CIRM-CF, Centre International des Ressources Microbiennes-Champignons Filamenteux, Marseille, France.

ORCID-Profile: Grégoire Pasquier, Eric Dannaoui, Arnaud Fekkar, Anne-Cécile Normand, Milène Sasso, Laurence Lachaud

Zitieren

APA

Pasquier, G., Harmand, P. O., Le Feur, L., Guemas, E., Bellanger, A. P., Maubon, D., Favel, A., Cottrel, C., Hasseine, L., Sabou, M., Dannaoui, E., Fekkar, A., Normand, A. C., Gangneux, J. P., Delhaes, L., Sasso, M., & Lachaud, L. (2026). Antifungal susceptibility and molecular characterization of clinical and environmental isolates of Schizophyllum commune. Journal of Clinical Microbiology, 64(3). https://doi.org/10.1128/jcm.01442-25

Vancouver

Pasquier G, Harmand PO, Le Feur L, Guemas E, Bellanger AP, Maubon D, et al. Antifungal susceptibility and molecular characterization of clinical and environmental isolates of Schizophyllum commune. Journal of Clinical Microbiology. 2026;64(3). doi:10.1128/jcm.01442-25

BibTeX
@article{Pasquier2026,
  author = {Pasquier, Grégoire and Harmand, Pierre-Olivier and Le Feur, Laura and Guemas, Emilie and Bellanger, Anne Pauline and Maubon, Danièle and Favel, Anne and Cottrel, Claire and Hasseine, Lilia and Sabou, Marcela and Dannaoui, Eric and Fekkar, Arnaud and Normand, Anne-Cécile and Gangneux, Jean-Pierre and Delhaes, Laurence and Sasso, Milène and Lachaud, Laurence},
  title = {Antifungal susceptibility and molecular characterization of clinical and environmental isolates of Schizophyllum commune},
  journal = {Journal of Clinical Microbiology},
  year = {2026},
  volume = {64},
  number = {3},
  doi = {10.1128/jcm.01442-25}
}
Kostenlos starten →